<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H2646FB8F0EFA493C8E04611364C8C9DC" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 8172 IH: Improving Diagnosis in Medicine Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-06-22</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 8172</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220622">June 22, 2022</action-date><action-desc><sponsor name-id="B001292">Mr. Beyer</sponsor> (for himself and <cosponsor name-id="S001216">Ms. Schrier</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To improve the quality, appropriateness, and effectiveness of diagnosis in health care, and for other purposes.</official-title></form><legis-body id="H7FAC9B76231A4D65A5B379E208B30211" style="OLC"><section section-type="section-one" id="H11697EE44EE94B78B5B80C86144C1749"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Improving Diagnosis in Medicine Act of 2022</short-title></quote>.</text></section><section id="HAA9835B0DF014837A2224DFB48DDD745"><enum>2.</enum><header>Research program to improve diagnostic safety and quality</header><text display-inline="no-display-inline">Part B of title IX of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/299b">42 U.S.C. 299b et seq.</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HCE4F25AB9BD94EAA818660BDB2652E84"><section id="HF60EF594E97F4F4E93CE13620366F135"><enum>918.</enum><header>Research program to improve diagnostic safety and quality</header><subsection id="H1E7ACAEF885248DD8DD4884634A31F95"><enum>(a)</enum><header>In general</header><text>The Director shall establish a comprehensive program of research and quality improvement to—</text><paragraph id="HCDDAFDDAA4D04750AF33E5630BC5295C"><enum>(1)</enum><text>assess and understand diagnostic errors, including diagnostic delays, and how to eliminate common failures in the diagnostic process that lead to significant patient harm; and </text></paragraph><paragraph id="HB3F31C3ED4C54D289AA717427DC7E8C5"><enum>(2)</enum><text>identify, develop, implement, and disseminate evidence-based strategies and best practices for improving diagnostic quality, safety, and health care value. </text></paragraph></subsection><subsection id="H4BF90EA7DC0F4DAF845D8DF9B81CF1FA"><enum>(b)</enum><header>Activities</header><text>The program established under subsection (a) shall include the following:</text><paragraph id="HD0472DBBD144414B9040D714B21F7CBD"><enum>(1)</enum><header>Continuum of research</header><text>A portfolio of conducted and supported activities that is consistent with the general, research, implementation, and dissemination activities of the Center for Quality Improvement and Patient Safety, as described in section 933, including—</text><subparagraph id="H9BB0762AF2084840A0EE279E9A043A4D"><enum>(A)</enum><text>investigator-initiated research to assess diagnostic errors and identify improved methods to prevent errors and the harm they cause;</text></subparagraph><subparagraph id="H4784D7DF3EF944348778E733D5502A79"><enum>(B)</enum><text>translation and synthesis of research findings and development of tools for implementing prevention strategies into practice;</text></subparagraph><subparagraph id="HF77CF0C4E5CC4BAB9094E3FF2B7D0DED"><enum>(C)</enum><text>implementation research to refine evidence-based tools for improving diagnostic processes and effectively integrate these solutions into practice; and</text></subparagraph><subparagraph id="HCEDEB26110AD4A7AA4E5A412D2CB112D"><enum>(D)</enum><text>dissemination to promote implementation of effective methods, strategies and tools for wide-scale improvement.</text></subparagraph></paragraph><paragraph id="H5A3D4A725C074651AEB581B8FDC662B3"><enum>(2)</enum><header>Research centers of diagnostic excellence</header><text display-inline="yes-display-inline">Grants or contracts awarded to public or private entities, in geographically diverse locations throughout the United States, that link research directly with clinical practice and that may include—</text><subparagraph id="H81D61B4936A2430B920472D89AC91448"><enum>(A)</enum><text>academic medical and institutional research centers that combine demonstrated multidisciplinary expertise in diagnostic outcomes or quality improvement research with linkages directly or through national, state or local stakeholder partner organizations to relevant sites of care; and</text></subparagraph><subparagraph id="H51319EBD6ABD466789097B4123716156"><enum>(B)</enum><text>provider-based research networks, including plan, facility, or delivery system sites of care (especially primary care), that can evaluate outcomes and evaluate and promote quality improvement approaches. </text></subparagraph></paragraph><paragraph id="HD1055384A09D4B9798F6F310DB581596"><enum>(3)</enum><header>Financial assistance</header><text display-inline="yes-display-inline">The Director may provide financial assistance to assist in meeting the costs of planning and establishing new centers, as well as operating existing and new centers, pursuant to section 902(c).</text></paragraph><paragraph id="H272A5E2B26C74B1BB2E673E89798DF85"><enum>(4)</enum><header>Stakeholder engagement</header><text display-inline="yes-display-inline">The Director shall identify and enter into a supporting agreement (grant or contract) with a nonprofit entity that convenes a coalition of diverse health care stakeholders for the purpose of—</text><subparagraph id="H17D823C90442422C8A6423FACC7F1B91"><enum>(A)</enum><text>raising attention to diagnostic safety and quality concerns;</text></subparagraph><subparagraph id="H2A3FA29774EE4275A146A8B70B5C5B81"><enum>(B)</enum><text>facilitating learning, adoption and spread of effective quality improvement interventions; and</text></subparagraph><subparagraph id="H187CED9F9E6D4B188D5CAFC858483493"><enum>(C)</enum><text>catalyzing novel actions by individual member organizations to reduce harms from diagnostic error and improve patient outcomes. </text></subparagraph></paragraph></subsection><subsection id="H0209401E0596450C9C3495B762EB345B"><enum>(c)</enum><header>Authorization of appropriations</header><paragraph id="H198D308B64FE443493726B1DF8B2C406"><enum>(1)</enum><header>In general</header><text>To carry out this section, there is authorized to be appropriated $20,000,000 for fiscal year 2023, $25,000,000 for fiscal year 2024, $30,000,000 for fiscal year 2025, and $35,000,000 for each of fiscal years 2026 and 2027.</text></paragraph><paragraph id="HD5384F46A930471AB6DBF90793D6C76D"><enum>(2)</enum><header>Reservation</header><text>Of the amount appropriated under paragraph (1) for a fiscal year, $700,000 shall be allocated to carrying out the purpose described in subsection (b)(4).</text></paragraph><paragraph id="HEB829B9F2CC6417F9A48806FAC56493F"><enum>(3)</enum><header>Availability</header><text>Amounts appropriated under this section shall remain available until expended.</text></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></section><section id="HF6E4331A810E44909BA8A91EB23843AF"><enum>3.</enum><header>Fellowships and training grants</header><subsection id="H05025076B1324B458C8EAE362D0F2C70"><enum>(a)</enum><header>Ruth Kirchstein awards</header><text display-inline="yes-display-inline">Section 487(a) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/288">42 U.S.C. 288(a)</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HFFFE0400763A47E191BBA248104E77FC"><paragraph id="H7C9B0EF0BD3F4C23B2048B32525E1A62" indent="up1"><enum>(5)</enum><text>For purposes of the program under this subsection, biomedical and behavioral research includes diagnostic safety and quality research.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H6E712CBDA74744CAA7516B91266E95E8"><enum>(b)</enum><header>AHRQ programs</header><text>Section 902(b)(1) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/299a">42 U.S.C. 299a(b)(1)</external-xref>) is amended—</text><paragraph id="HC7AB86F5EEC74D31A8C74055D64E69B2"><enum>(1)</enum><text>by inserting <quote>and diagnostic safety and quality</quote> after <quote>subsection (a)</quote>; and</text></paragraph><paragraph id="H88FB33B0A7CA4949B55D4CD78AC736CC"><enum>(2)</enum><text>by striking <quote>under section 487(d)(3)</quote> and inserting <quote>for purposes of carrying out section 487</quote>.</text></paragraph></subsection></section><section id="HCE14949B803C4392B8043E78FA32703F"><enum>4.</enum><header>Quality measure development</header><text display-inline="no-display-inline">Section 931(c)(2) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/299b-31">42 U.S.C. 299b–31(c)(2)</external-xref>) is amended—</text><paragraph id="H5E2A5435BE1B4A439EBD7772BD5C7211"><enum>(1)</enum><text display-inline="yes-display-inline">by redesignating subparagraphs (B) through (J) as subparagraphs (C) through (K), respectively; and</text></paragraph><paragraph id="HB6BEB71858FC4CFE85A50AE5B9B799BC"><enum>(2)</enum><text>by inserting after subparagraph (A) the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H6B34A7941DE343E3979FCB3DE4089067"><subparagraph id="HF3C5CBBB4596474EB2490CA846C2B265"><enum>(B)</enum><text>diagnostic safety and quality;</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section><section id="H4F05E5E285EF4049A373B14F88F12798"><enum>5.</enum><header>Data for research and improvement</header><text display-inline="no-display-inline">Section 937(f) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/299b-37">42 U.S.C. 299b–37(f)</external-xref>) is amended—</text><paragraph id="HB694624D0C484726B3309AEF4B2EF93F"><enum>(1)</enum><text display-inline="yes-display-inline">by striking <quote>The Secretary</quote> and inserting the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HF8A3AF3DF7844D899D755C729D7D54FB"><paragraph id="H3FF1CB23538841F4AF55F77D1A83FD76"><enum>(1)</enum><header>In general</header><text>The Secretary</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></paragraph><paragraph id="HE7273CBB315C4CE1A17C7348E2551E3D"><enum>(2)</enum><text>adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HD448CF3FECDF4D81B531C774D1EEDC51"><paragraph id="H482E994E9C3447AAAD59C4A479EE31EF"><enum>(2)</enum><header>Consultation with expert panel</header><text>In carrying out paragraph (1), the Secretary, in coordination with the Director, the Administrator of the Centers for Medicare &amp; Medicaid Services, the National Coordinator for Health Information Technology, and the Director of the National Library of Medicine, shall convene an expert panel to consider and make recommendations regarding the types, sources, and availability of data needed to accelerate diagnostic safety and quality research, training, and measure development as specified in section 918, including data related to racial, ethnic, and language attributes; gender, age, geography, and socioeconomic conditions; the specificity, interoperability, and socio-technical aspects of electronic vocabularies and ontologies related to presenting symptoms and diagnostic certainty; and the development and use of symptom-based clinical registries. Such panel shall consider enhanced data capabilities that are necessary to support both research and improvement of diagnostic safety and quality.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section><section id="H668419EDE1394ECCB9B3D2D6627A7CC7"><enum>6.</enum><header>Interagency Council on Improving Diagnosis in Health Care</header><subsection id="H7082628925184499BB7A7F92CE4B7144"><enum>(a)</enum><header>Establishment</header><text>The Secretary of Health and Human Services (in this section referred to as the <quote>Secretary</quote>) shall establish within the Office of the Secretary an interagency council to be known as the Interagency Council on Improving Diagnosis in Health Care (referred to in this section as the <quote>Council</quote>).</text></subsection><subsection id="H10A697650DDC48FDBCAB86C0413620BB"><enum>(b)</enum><header>Objectives</header><text display-inline="yes-display-inline">The Council shall furnish a forum for the agencies represented on the Council to discuss ways to accomplish the following objectives:</text><paragraph id="HA957BC43F50D465494B74AF182697CE4"><enum>(1)</enum><text display-inline="yes-display-inline">Enhance the quality, appropriateness, and effectiveness of diagnosis in health care through—</text><subparagraph id="HDDF9CEDB212D426B995CB720B81A74ED"><enum>(A)</enum><text display-inline="yes-display-inline">the establishment and support of a broad base of scientific research;</text></subparagraph><subparagraph id="H66898BF69DE4406DBC87FAD4D788CE46"><enum>(B)</enum><text>the dissemination and implementation of the results of such research; and</text></subparagraph><subparagraph id="H4DCDAAED6F3440B98F6EA471AA6566FE"><enum>(C)</enum><text>the promotion of improvements in clinical and health system practices.</text></subparagraph></paragraph><paragraph id="H3CFF66A058FF42D1A15DA3D5E7002F96"><enum>(2)</enum><text display-inline="yes-display-inline">Identify and eliminate systemic barriers to supporting research in improving diagnosis in health care.</text></paragraph><paragraph id="H4539C6BCC0D14DB1ACE5B09A67289EDB"><enum>(3)</enum><text display-inline="yes-display-inline">Identify knowledge gaps, research and data needs, and opportunities congruent with agency missions to strengthen the clinical and translational research pipeline to improve diagnostic safety and quality, including potential collaborative research initiatives among 2 or more agencies, offices, institutes, or centers within the Department of Health and Human Services or other Federal agencies or offices.</text></paragraph></subsection><subsection id="H4B507FECC2D44AA1B1FCF5FD81AE26F6"><enum>(c)</enum><header>Membership</header><paragraph id="H1F1E9DD16DC74EC9B5BC80ACAA46717F"><enum>(1)</enum><header>Chairperson</header><text>The Director of the Agency for Healthcare Research and Quality (or the Director’s designee) shall be the Chairperson of the Council.</text></paragraph><paragraph id="H25C4D91CE581478095236FF0696C7055"><enum>(2)</enum><header>Members</header><subparagraph id="H6754DEC8CB36433ABE383C47032656E1"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">In addition to the Chairperson, the Council shall be comprised of the following:</text><clause id="HDBB6CFFA5DF4458D90000D329F7C1DAF"><enum>(i)</enum><text display-inline="yes-display-inline">At least 1 designee from each of the following, appointed by the head of the applicable department or agency:</text><subclause id="H06FDFDDE5E1C433CA50A38553980A79A"><enum>(I)</enum><text>The Centers for Disease Control and Prevention.</text></subclause><subclause id="HDCED7482E72041C8BA5D3F791D4793DB"><enum>(II)</enum><text>The Centers for Medicare &amp; Medicaid Services.</text></subclause><subclause id="H2B224D64F6304C75B97DEB59FA00CAAC"><enum>(III)</enum><text>The Department of Veterans Affairs.</text></subclause><subclause id="H1EB15C9121C9435B9A57795FE846DA3E"><enum>(IV)</enum><text>The Congressionally Directed Medical Research Program of the Department of Defense.</text></subclause><subclause id="H7DEE94E2D8E14985989F4A3FD0AED0C8"><enum>(V)</enum><text>The Office of the National Coordinator for Health Information Technology.</text></subclause></clause><clause id="H2EBD72602DD745A6BB0F5AD12B1DEC12"><enum>(ii)</enum><text display-inline="yes-display-inline">Designees from the National Institutes of Health, including a least 1 designee from each of the following:</text><subclause id="HBDC3B934BBBD40B5A39725FB18263F3B"><enum>(I)</enum><text>The National Cancer Institute.</text></subclause><subclause id="H6593B0D3C0844A46B2C34CAAFD4B3D9F"><enum>(II)</enum><text display-inline="yes-display-inline">The National Center for Advancing Translational Sciences.</text></subclause><subclause id="HC2CB9BF4C29C42198DEB4B2B0B518CB8"><enum>(III)</enum><text>The National Institute of Allergy and Infectious Diseases.</text></subclause><subclause id="H87DCDA0CD9CE4DB38AFC1D043C66C90E"><enum>(IV)</enum><text>The National Heart, Lung, and Blood Institute.</text></subclause><subclause id="HBD1BEF1D33AB4089814E59B589542915"><enum>(V)</enum><text display-inline="yes-display-inline">The National Institute of Neurological Disorders and Stroke.</text></subclause><subclause id="H0F53E3FEA6234A7D80CBF209617D4AA2"><enum>(VI)</enum><text>The National Library of Medicine.</text></subclause><subclause id="HEC3B77F128CD4556B6EFDEC1C8DBAE8A"><enum>(VII)</enum><text>The National Institute on Minority Health and Health Disparities.</text></subclause><subclause id="HE86F342ECB254BA584C487D135FC91E3"><enum>(VIII)</enum><text>The National Institute of Nursing Research.</text></subclause><subclause id="HB83D0C23E87B4AA895D9F5865CE9F9AD"><enum>(IX)</enum><text>The Eunice Kennedy Shriver National Institute of Child Health and Human Development.</text></subclause></clause><clause id="H2FCEF5CB8ABA4F86BEA667DCD0F253CA"><enum>(iii)</enum><text display-inline="yes-display-inline">Designees from such other national research institutes and national centers as may be appropriate, as determined by the Director of the National Institutes of Health.</text></clause></subparagraph><subparagraph id="H6091CADB4BB048D2BCEE59BA4CFCBC81"><enum>(B)</enum><header>Additional members</header><text>In addition to the designees under subparagraph (A), the Council may include such other designees from Federal departments or agencies as the Chairperson of the Council deems appropriate.</text></subparagraph><subparagraph id="HE7A6897D73E648ECB237E1D5B6660846"><enum>(C)</enum><header>Designation</header><text display-inline="yes-display-inline">A person appointed to the Council as a designee shall be a senior official or employee of the department or agency whose responsibilities and subject matter expertise are relevant to the Council’s objectives listed in subsection (b), as determined by the designating official.</text></subparagraph></paragraph></subsection><subsection id="H1EA4CFE0DFC04C1AA458F918E77EC70A"><enum>(d)</enum><header>Strategic plan; reports</header><paragraph id="H3A9DBFE3FA264AA78F052EFF3E950B06"><enum>(1)</enum><header>Strategic Federal Plan to Improve Diagnosis in Health Care</header><text display-inline="yes-display-inline">Not later than 18 months after the date of enactment of this Act, the Council shall develop, submit to the Secretary and Congress, and make publicly available a strategic plan, to be known as the Strategic Federal Plan to Improve Diagnosis. Consistent with the objectives listed in subsection (b), such strategic plan—</text><subparagraph id="HE0D366047D7C4F79B7244A36C90F3B9E"><enum>(A)</enum><text>shall identify coordinated opportunities to enhance scientific research and reduce systemic barriers in order to improve diagnosis in health care; and</text></subparagraph><subparagraph id="H64B3ED934320473D87282F411FEBEEE1"><enum>(B)</enum><text display-inline="yes-display-inline">shall include administrative policy recommendations, and may include such legislative recommendations as the Council may wish to make, including recommendations on opportunities to remove barriers to, and enhance, interagency coordination in the planning, conduct, and funding of, such research.</text></subparagraph></paragraph><paragraph id="HC767B987C4774B2AB48266E39CEDFE10"><enum>(2)</enum><header>Reports to Congress</header><text display-inline="yes-display-inline">Not later than July 31 of every odd-numbered year beginning with the first such year after the date of submission of the first Strategic Federal Plan to Improve Diagnosis under paragraph (1), the Council shall prepare, submit to the Secretary and Congress, and make publicly available an updated Strategic Federal Plan to Improve Diagnosis that—</text><subparagraph id="H2173A4E88C2D4CAC8E8FF1FE431CF76B"><enum>(A)</enum><text display-inline="yes-display-inline">includes such updates as the Council determines to be appropriate;</text></subparagraph><subparagraph id="H7B5C781192C24EEE8F2F62D9057D99E8"><enum>(B)</enum><text display-inline="yes-display-inline">includes information on the overall progress of the Federal Government in reducing barriers to research on, and supporting projects to improve, diagnosis in health care; and</text></subparagraph><subparagraph id="HD613C8BE113D4A09ABC59A029E827E38"><enum>(C)</enum><text>includes administrative policy recommendations, and may include legislative recommendations, including addressing any needs for greater legislative authority to meet the objectives listed in subsection (b). </text></subparagraph></paragraph></subsection><subsection id="H26D8D61BDB1244C1A18E36628ECB7D7D"><enum>(e)</enum><header>Authorization of appropriations</header><text>To carry out this section, there are authorized to be appropriated $1,500,000 for each of fiscal years 2023 through 2027.</text></subsection></section><section id="H39CC569DFA7E4948B6A6CD0C98E488A7"><enum>7.</enum><header>National academies report</header><subsection id="H2F11937EF53445F7AB92BBC87967B148"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Director of the Agency for Healthcare Research and Quality shall seek to enter into a contract with the National Academies of Sciences, Engineering, and Medicine under which such National Academies conducts a study and issues a report on disparities in diagnostic safety and quality that—</text><paragraph id="H95E23C5D7D554D518936BFC73C443E26"><enum>(1)</enum><text>identifies what is known about the burden and causes of such disparities, including racial, ethnic, socioeconomic, age, gender, geography, language proficiency, and intersectional interactions; and </text></paragraph><paragraph id="H760C5C92E44340218CBC8C85BCE461B5"><enum>(2)</enum><text display-inline="yes-display-inline">includes recommendations on specific actions that policymakers, researchers, clinicians, and other stakeholders can take to eliminate such burdens. </text></paragraph></subsection><subsection id="H58BCF9D0D2474CACB8194022AD672005"><enum>(b)</enum><header>Authorization of appropriations</header><text>To carry out this section, there is authorized to be appropriated $1,500,000 for fiscal year 2023, to remain available until expended.</text></subsection></section></legis-body></bill> 

